NCT00030355 2013-03-22
Homoharringtonine in Treating Patients With Refractory Acute Promyelocytic Leukemia
National Cancer Institute (NCI)
Phase 1/2 Withdrawn
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)